SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
People carry symbolic coffins in front of the British prime minister's office in London on October 12, 2021. (Photo: Hasan Esen/Anadolu Agency via Getty Images)
Dozens of youth-led advocacy groups from around the world published an open letter Wednesday urging the European Union, the United Kingdom, Norway, and Switzerland to immediately end their opposition to a proposed patent waiver for coronavirus vaccines, which still remain out of reach for billions of people in poor countries.
"Publicly funded vaccines should not be used to make pharmaceutical giants richer."
"We write to you as young people, frustrated and disappointed with the way that the pandemic has been handled," reads the new letter, which was signed by more than 40 student and youth organizations based in India, South Africa, Zambia, France, Argentina, and other nations.
"The blocking of the TRIPS waiver and the failure to share the necessary technology has fundamentally undermined the right to live full lives," the letter continues. "There is no reason to leave the burden of fixing this system to us as future generations when immediate solutions exist."
Throughout the roughly 14 months since India and South Africa first introduced their plan for a temporary patent waiver at the World Trade Organization, European countries have repeatedly stonewalled the proposal and pushed alternatives that critics say wouldn't challenge the pharmaceutical industry's monopoly control over vaccine production.
Under pressure from African countries to change its stance, the E.U. leadership has reiterated its opposition to the patent waiver in recent days.
Proponents argue that a suspension of intellectual property protections--paired with vaccine technology transfers that rich nations and pharmaceutical companies have also opposed--would allow developing countries to independently produce coronavirus vaccines for their populations.
"Pharmaceutical companies have claimed that the vaccine technology is too complex to be licensed or shared. Contrary to these claims, experts argue that the mRNA vaccine is easier to develop and Doctors Without Borders recently published a report showing that there are 120 possible manufacturers in the Global South," the youth organizations wrote Wednesday. "Thus, a temporary waiver of the TRIPS agreement can significantly increase the production rate and ensure a wider, more equitable global vaccine access."
In the absence of a patent waiver or tech transfer, low-income nations have largely been forced to rely on vaccine charity efforts that have been plagued by cash shortages, mismanagement, and inadequate donations from the rich countries hoarding much of the global supply.
The result has been vast and persistent inequities in vaccine distribution. The latest figures from Our World in Data show that fewer than 11% of people in low-income countries have received at least one coronavirus vaccine dose.
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines."
One commentator recently observed that "out of more than nine billion vaccines doses produced, Africa has only received approximately 540 million (about 6% of all Covid vaccines, despite having 17% of the world's population) and
administered 309 million doses."
According to an analysis released Wednesday by the People's Vaccine Alliance, the E.U. is set to throw away almost twice as many coronavirus vaccine doses as it has donated to Africa so far this year.
In their letter Wednesday, the youth organizations warned that "this extreme vaccine inequality perpetuates the current crisis" and "threatens to create dangerous new variants."
"Publicly funded vaccines should not be used to make pharmaceutical giants richer," the groups wrote. "Unelected, undemocratic pharmaceutical companies cannot continue to dictate the global distribution of vaccines... We implore you to unconditionally support the TRIPS waiver and facilitate Covid-19-related technology and knowledge transfer before the next WTO meeting at the end of March 2022."
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines," they added. "Our common success against this pandemic lies in your hands."
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Dozens of youth-led advocacy groups from around the world published an open letter Wednesday urging the European Union, the United Kingdom, Norway, and Switzerland to immediately end their opposition to a proposed patent waiver for coronavirus vaccines, which still remain out of reach for billions of people in poor countries.
"Publicly funded vaccines should not be used to make pharmaceutical giants richer."
"We write to you as young people, frustrated and disappointed with the way that the pandemic has been handled," reads the new letter, which was signed by more than 40 student and youth organizations based in India, South Africa, Zambia, France, Argentina, and other nations.
"The blocking of the TRIPS waiver and the failure to share the necessary technology has fundamentally undermined the right to live full lives," the letter continues. "There is no reason to leave the burden of fixing this system to us as future generations when immediate solutions exist."
Throughout the roughly 14 months since India and South Africa first introduced their plan for a temporary patent waiver at the World Trade Organization, European countries have repeatedly stonewalled the proposal and pushed alternatives that critics say wouldn't challenge the pharmaceutical industry's monopoly control over vaccine production.
Under pressure from African countries to change its stance, the E.U. leadership has reiterated its opposition to the patent waiver in recent days.
Proponents argue that a suspension of intellectual property protections--paired with vaccine technology transfers that rich nations and pharmaceutical companies have also opposed--would allow developing countries to independently produce coronavirus vaccines for their populations.
"Pharmaceutical companies have claimed that the vaccine technology is too complex to be licensed or shared. Contrary to these claims, experts argue that the mRNA vaccine is easier to develop and Doctors Without Borders recently published a report showing that there are 120 possible manufacturers in the Global South," the youth organizations wrote Wednesday. "Thus, a temporary waiver of the TRIPS agreement can significantly increase the production rate and ensure a wider, more equitable global vaccine access."
In the absence of a patent waiver or tech transfer, low-income nations have largely been forced to rely on vaccine charity efforts that have been plagued by cash shortages, mismanagement, and inadequate donations from the rich countries hoarding much of the global supply.
The result has been vast and persistent inequities in vaccine distribution. The latest figures from Our World in Data show that fewer than 11% of people in low-income countries have received at least one coronavirus vaccine dose.
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines."
One commentator recently observed that "out of more than nine billion vaccines doses produced, Africa has only received approximately 540 million (about 6% of all Covid vaccines, despite having 17% of the world's population) and
administered 309 million doses."
According to an analysis released Wednesday by the People's Vaccine Alliance, the E.U. is set to throw away almost twice as many coronavirus vaccine doses as it has donated to Africa so far this year.
In their letter Wednesday, the youth organizations warned that "this extreme vaccine inequality perpetuates the current crisis" and "threatens to create dangerous new variants."
"Publicly funded vaccines should not be used to make pharmaceutical giants richer," the groups wrote. "Unelected, undemocratic pharmaceutical companies cannot continue to dictate the global distribution of vaccines... We implore you to unconditionally support the TRIPS waiver and facilitate Covid-19-related technology and knowledge transfer before the next WTO meeting at the end of March 2022."
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines," they added. "Our common success against this pandemic lies in your hands."
Dozens of youth-led advocacy groups from around the world published an open letter Wednesday urging the European Union, the United Kingdom, Norway, and Switzerland to immediately end their opposition to a proposed patent waiver for coronavirus vaccines, which still remain out of reach for billions of people in poor countries.
"Publicly funded vaccines should not be used to make pharmaceutical giants richer."
"We write to you as young people, frustrated and disappointed with the way that the pandemic has been handled," reads the new letter, which was signed by more than 40 student and youth organizations based in India, South Africa, Zambia, France, Argentina, and other nations.
"The blocking of the TRIPS waiver and the failure to share the necessary technology has fundamentally undermined the right to live full lives," the letter continues. "There is no reason to leave the burden of fixing this system to us as future generations when immediate solutions exist."
Throughout the roughly 14 months since India and South Africa first introduced their plan for a temporary patent waiver at the World Trade Organization, European countries have repeatedly stonewalled the proposal and pushed alternatives that critics say wouldn't challenge the pharmaceutical industry's monopoly control over vaccine production.
Under pressure from African countries to change its stance, the E.U. leadership has reiterated its opposition to the patent waiver in recent days.
Proponents argue that a suspension of intellectual property protections--paired with vaccine technology transfers that rich nations and pharmaceutical companies have also opposed--would allow developing countries to independently produce coronavirus vaccines for their populations.
"Pharmaceutical companies have claimed that the vaccine technology is too complex to be licensed or shared. Contrary to these claims, experts argue that the mRNA vaccine is easier to develop and Doctors Without Borders recently published a report showing that there are 120 possible manufacturers in the Global South," the youth organizations wrote Wednesday. "Thus, a temporary waiver of the TRIPS agreement can significantly increase the production rate and ensure a wider, more equitable global vaccine access."
In the absence of a patent waiver or tech transfer, low-income nations have largely been forced to rely on vaccine charity efforts that have been plagued by cash shortages, mismanagement, and inadequate donations from the rich countries hoarding much of the global supply.
The result has been vast and persistent inequities in vaccine distribution. The latest figures from Our World in Data show that fewer than 11% of people in low-income countries have received at least one coronavirus vaccine dose.
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines."
One commentator recently observed that "out of more than nine billion vaccines doses produced, Africa has only received approximately 540 million (about 6% of all Covid vaccines, despite having 17% of the world's population) and
administered 309 million doses."
According to an analysis released Wednesday by the People's Vaccine Alliance, the E.U. is set to throw away almost twice as many coronavirus vaccine doses as it has donated to Africa so far this year.
In their letter Wednesday, the youth organizations warned that "this extreme vaccine inequality perpetuates the current crisis" and "threatens to create dangerous new variants."
"Publicly funded vaccines should not be used to make pharmaceutical giants richer," the groups wrote. "Unelected, undemocratic pharmaceutical companies cannot continue to dictate the global distribution of vaccines... We implore you to unconditionally support the TRIPS waiver and facilitate Covid-19-related technology and knowledge transfer before the next WTO meeting at the end of March 2022."
"The vaccination strategy will only be effective if the whole of humanity has access to vaccines," they added. "Our common success against this pandemic lies in your hands."